Matt Davidson Insider Trades & Stock Holdings

Chief Development Officer · Adial Pharmaceuticals, Inc. · Latest filing Jun 12, 2026

Matt Davidson, Chief Development Officer at Adial Pharmaceuticals, Inc. has 2 Form 4 trades on file since Jun 11, 2026. Latest filing: acquired 232.42K shares of $ADIL on Jun 12, 2026.

Trades on file: 2
Open-market bought: $0
Open-market sold: $0
Net open-market: $0
Latest filing: Jun 12, 2026

All insider trades by Matt Davidson

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 12, 2026	$ADIL	Buy (Grant or award)	232.42K	$0	—			-9.1%	-5.0%		Chief Development Officer		Read
Jun 11, 2026	$ADIL	Buy (Grant or award)	1.92K	—	—			-12.8%	-5.0%		Chief Development Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Matt Davidson traded

$ADIL

Frequently asked questions

What was Matt Davidson's latest insider trade?

acquired 232.42K shares of $ADIL on Jun 12, 2026.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text